Alcon AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0432492467
CHF
62.50
-0.5 (-0.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

832.58 k

Shareholding (Dec 2023)

FII

45.29%

Held by 1141 FIIs

DII

52.04%

Held by 32 DIIs

Promoter

0.03%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.14%

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.40 times
2

The company has declared negative results in Dec'2023 after 2 consecutive positive quarters

3

With ROE of 5.64%, it has a Very Expensive valuation with a 1.70 Price to Book Value

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 31,751 Million ()

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.06%

stock-summary
Debt Equity

0.18

stock-summary
Return on Equity

5.48%

stock-summary
Price to Book

1.81

Revenue and Profits:
Net Sales:
2,144 Million
(Quarterly Results - Jun 2025)
Net Profit:
145 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.26%
0%
-0.26%
6 Months
-13.91%
0%
-13.91%
1 Year
-18.36%
0%
-18.36%
2 Years
-2.01%
0%
-2.01%
3 Years
-4.87%
0%
-4.87%
4 Years
-19.0%
0%
-19.0%
5 Years
9.92%
0%
9.92%

Alcon AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.77%
EBIT Growth (5y)
42.14%
EBIT to Interest (avg)
6.34
Debt to EBITDA (avg)
1.40
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.36
Tax Ratio
15.88%
Dividend Payout Ratio
15.44%
Pledged Shares
0
Institutional Holding
59.58%
ROCE (avg)
4.14%
ROE (avg)
3.73%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
1.70
EV to EBIT
25.23
EV to EBITDA
13.74
EV to Capital Employed
1.61
EV to Sales
3.76
PEG Ratio
NA
Dividend Yield
0.07%
ROCE (Latest)
6.37%
ROE (Latest)
5.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 9 Schemes (2.64%)

Foreign Institutions

Held by 1141 Foreign Institutions (45.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -3.55% vs 1.27% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -53.78% vs 26.24% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,144.20",
          "val2": "2,223.20",
          "chgp": "-3.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "497.20",
          "val2": "711.10",
          "chgp": "-30.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "42.10",
          "val2": "44.00",
          "chgp": "-4.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-57.80",
          "val2": "-11.70",
          "chgp": "-394.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "145.40",
          "val2": "314.60",
          "chgp": "-53.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "109.00%",
          "val2": "194.50%",
          "chgp": "-8.55%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.72% vs 2.06% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.42% vs 173.62% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,728.30",
          "val2": "8,496.80",
          "chgp": "2.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,329.40",
          "val2": "2,158.60",
          "chgp": "7.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "169.10",
          "val2": "169.80",
          "chgp": "-0.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.50",
          "val2": "-127.60",
          "chgp": "97.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "896.50",
          "val2": "875.30",
          "chgp": "2.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "143.00%",
          "val2": "124.90%",
          "chgp": "1.81%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
2,144.20
2,223.20
-3.55%
Operating Profit (PBDIT) excl Other Income
497.20
711.10
-30.08%
Interest
42.10
44.00
-4.32%
Exceptional Items
-57.80
-11.70
-394.02%
Consolidate Net Profit
145.40
314.60
-53.78%
Operating Profit Margin (Excl OI)
109.00%
194.50%
-8.55%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -3.55% vs 1.27% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -53.78% vs 26.24% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
8,728.30
8,496.80
2.72%
Operating Profit (PBDIT) excl Other Income
2,329.40
2,158.60
7.91%
Interest
169.10
169.80
-0.41%
Exceptional Items
-3.50
-127.60
97.26%
Consolidate Net Profit
896.50
875.30
2.42%
Operating Profit Margin (Excl OI)
143.00%
124.90%
1.81%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.72% vs 2.06% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 2.42% vs 173.62% in Dec 2023

stock-summaryCompany CV
About Alcon AG stock-summary
stock-summary
Alcon AG
Pharmaceuticals & Biotechnology
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.
Company Coordinates stock-summary
Company Details
Rue Louis-d'Affry 6 , FRIBOURG None : 1701
stock-summary
Tel: 41 589 112110
stock-summary
Registrar Details